368 related articles for article (PubMed ID: 37371105)
1. The Biologist's Guide to the Glucocorticoid Receptor's Structure.
Deploey N; Van Moortel L; Rogatsky I; Peelman F; De Bosscher K
Cells; 2023 Jun; 12(12):. PubMed ID: 37371105
[TBL] [Abstract][Full Text] [Related]
2. Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids.
Rogatsky I; Hittelman AB; Pearce D; Garabedian MJ
Mol Cell Biol; 1999 Jul; 19(7):5036-49. PubMed ID: 10373553
[TBL] [Abstract][Full Text] [Related]
3. Role of Phosphorylation in the Modulation of the Glucocorticoid Receptor's Intrinsically Disordered Domain.
Kumar R; Thompson EB
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30862072
[TBL] [Abstract][Full Text] [Related]
4. How to tame your genes: mechanisms of inflammatory gene repression by glucocorticoids.
Strickland BA; Ansari SA; Dantoft W; Uhlenhaut NH
FEBS Lett; 2022 Oct; 596(20):2596-2616. PubMed ID: 35612756
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain.
Garside H; Stevens A; Farrow S; Normand C; Houle B; Berry A; Maschera B; Ray D
J Biol Chem; 2004 Nov; 279(48):50050-9. PubMed ID: 15355994
[TBL] [Abstract][Full Text] [Related]
6. There goes the neighborhood: Assembly of transcriptional complexes during the regulation of metabolism and inflammation by the glucocorticoid receptor.
Greulich F; Hemmer MC; Rollins DA; Rogatsky I; Uhlenhaut NH
Steroids; 2016 Oct; 114():7-15. PubMed ID: 27192428
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into glucocorticoid receptor function.
Frank F; Ortlund EA; Liu X
Biochem Soc Trans; 2021 Nov; 49(5):2333-2343. PubMed ID: 34709368
[TBL] [Abstract][Full Text] [Related]
8. Acquired Glucocorticoid Resistance Due to Homologous Glucocorticoid Receptor Downregulation: A Modern Look at an Age-Old Problem.
Spies LL; Verhoog NJD; Louw A
Cells; 2021 Sep; 10(10):. PubMed ID: 34685511
[TBL] [Abstract][Full Text] [Related]
9. Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies.
Clarisse D; Offner F; De Bosscher K
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188430. PubMed ID: 32950642
[TBL] [Abstract][Full Text] [Related]
10. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.
Martens C; Bilodeau S; Maira M; Gauthier Y; Drouin J
Mol Endocrinol; 2005 Apr; 19(4):885-97. PubMed ID: 15591535
[TBL] [Abstract][Full Text] [Related]
11. Structural Analysis of the Glucocorticoid Receptor Ligand-Binding Domain in Complex with Triamcinolone Acetonide and a Fragment of the Atypical Coregulator, Small Heterodimer Partner.
Weikum ER; Okafor CD; D'Agostino EH; Colucci JK; Ortlund EA
Mol Pharmacol; 2017 Jul; 92(1):12-21. PubMed ID: 28396564
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid receptor alpha isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance.
Gross KL; Oakley RH; Scoltock AB; Jewell CM; Cidlowski JA
Mol Endocrinol; 2011 Jul; 25(7):1087-99. PubMed ID: 21527497
[TBL] [Abstract][Full Text] [Related]
13. A guide to changing paradigms of glucocorticoid receptor function-a model system for genome regulation and physiology.
Vettorazzi S; Nalbantoglu D; Gebhardt JCM; Tuckermann J
FEBS J; 2022 Oct; 289(19):5718-5743. PubMed ID: 34213830
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
[TBL] [Abstract][Full Text] [Related]
15. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
Vandevyver S; Dejager L; Tuckermann J; Libert C
Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
[TBL] [Abstract][Full Text] [Related]
16. Xenobiotics and the Glucocorticoid Receptor.
Gulliver LS
Toxicol Appl Pharmacol; 2017 Mar; 319():69-79. PubMed ID: 28174120
[TBL] [Abstract][Full Text] [Related]
17. Description of a Novel Mechanism Possibly Explaining the Antiproliferative Properties of Glucocorticoids in Duchenne Muscular Dystrophy Fibroblasts Based on Glucocorticoid Receptor GR and NFAT5.
Herbelet S; De Paepe B; De Bleecker JL
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287327
[TBL] [Abstract][Full Text] [Related]
18. The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor.
Yoshikawa N; Yamamoto K; Shimizu N; Yamada S; Morimoto C; Tanaka H
Mol Endocrinol; 2005 May; 19(5):1110-24. PubMed ID: 15677712
[TBL] [Abstract][Full Text] [Related]
19. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
20. Influence of flanking sequences on signaling between the activation function AF1 and DNA-binding domain of the glucocorticoid receptor.
Kumar R; Thompson EB
Arch Biochem Biophys; 2010 Apr; 496(2):140-5. PubMed ID: 20188692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
